Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mult Scler Relat Disord ; 23: 24-26, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29734135

RESUMO

Fingolimod is a commonly used treatment for highly active relapsing-remitting multiple sclerosis (MS). We describe the case of a 50-year old man on fingolimod since 2011 who presented, in April 2017, with a voluminous swelling of the left tonsil. A left tonsillectomy was performed, and histological exam disclosed a papillary squamous cell carcinoma of the palatine tonsil, with an in situ hybridization positive for human papillomavirus (HPV)-16 DNA. Neither lymph nodes involvement nor other metastases were detected. Fingolimod was stopped as a precautionary measure in May 2017, and the patient currently continues his follow up at our Department. Immunocompromised patients are at risk for developing HPV-related malignancies probably in light of the suppression of T-cell immunity, therefore an increased risk for HPV activation in MS patients treated with disease modifying therapies (DMTs) characterized by a more pronounced immunosuppressant activity cannot be excluded. Given the absence of studies on larger cohorts of MS patients exposed to DMTs, additional monitoring for HPV infection during fingolimod treatment is not currently recommended. However, vigilance for this possible association is warranted.


Assuntos
Carcinoma de Células Escamosas/etiologia , Cloridrato de Fingolimode/efeitos adversos , Imunossupressores/efeitos adversos , Infecções por Papillomavirus/etiologia , Neoplasias Tonsilares/etiologia , Carcinoma de Células Escamosas/diagnóstico por imagem , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/cirurgia , Cloridrato de Fingolimode/uso terapêutico , Papillomavirus Humano 16 , Humanos , Hospedeiro Imunocomprometido , Imunossupressores/uso terapêutico , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla Recidivante-Remitente/tratamento farmacológico , Infecções por Papillomavirus/diagnóstico por imagem , Infecções por Papillomavirus/patologia , Infecções por Papillomavirus/cirurgia , Neoplasias Tonsilares/diagnóstico por imagem , Neoplasias Tonsilares/patologia , Neoplasias Tonsilares/cirurgia
2.
Case Rep Otolaryngol ; 2014: 617424, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25276458

RESUMO

AMONG ALL THE POSSIBLE COMPLICATIONS OF AESTHETIC RHINOPLASTY, A RARE ONE IS THE DEVELOPMENT OF CYSTIC MASSES ON THE NASAL DORSUM: several theories suggest that cysts develop commonly by entrapment of nasal mucosa in the subcutaneous space, but they can also originate from foreign body reactions. This report deals with two cases of nasal dorsum cysts with different pathogenesis: both patients had undergone aesthetic rhinoplasty in the past (26 years ago and 14 years ago, resp.). Both cystic masses were removed via a direct open approach and nasal reconstruction was performed successfully with autologous vomer bone. The pathologic investigations showed a foreign body inclusion cyst associated with latex rubber in the first case and a sequestration of a mucosal-lined nasal bone was not removed at the time of primary rhinoplasty in the second case. A brief review of the literature focuses on the pathophysiology and treatment options for nasal dorsal cysts following aesthetic rhinoplasty.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA